2024-04-01 2025-03-31 false No description of principal activity Capium Accounts Production 1.1 13484277 2024-04-01 2025-03-31 13484277 bus:AbridgedAccounts 2024-04-01 2025-03-31 13484277 bus:Micro-entities 2024-04-01 2025-03-31 13484277 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 13484277 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13484277 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13484277 2024-04-01 2025-03-31 13484277 2025-03-31 13484277 bus:RegisteredOffice 2024-04-01 2025-03-31 13484277 core:WithinOneYear 2025-03-31 13484277 core:AfterOneYear 2025-03-31 13484277 1 2024-04-01 2025-03-31 13484277 bus:Director1 2024-04-01 2025-03-31 13484277 bus:Director1 2025-03-31 13484277 bus:Director1 2023-04-01 2024-03-31 13484277 2023-04-01 13484277 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 13484277 2023-04-01 2024-03-31 13484277 2024-03-31 13484277 core:WithinOneYear 2024-03-31 13484277 core:AfterOneYear 2024-03-31 13484277 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 13484277 core:ComputerEquipment 2024-04-01 2025-03-31 13484277 core:ComputerEquipment 2025-03-31 13484277 core:ComputerEquipment 2024-03-31 13484277 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 13484277 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 13484277 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 13484277 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 13484277 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 13484277 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 13484277 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 13484277 core:Non-currentFinancialInstruments 2025-03-31 13484277 core:Non-currentFinancialInstruments 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 13484277
England and Wales
MEDICOEUR CONSULTING LTD
Abridged Accounts
Period of accounts Start date: 01 April 2024 End date: 31 March 2025

MEDICOEUR CONSULTING LTD Contents Page For the year ended 31 March 2025
Statement of financial position | 1

MEDICOEUR CONSULTING LTD Statement of Financial Position As at 31 March 2025
|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Fixed assets |  |  | (169) |  |  | (169)
Current assets |  | 45,396 |  |  | 45,396 |
Creditors: amount falling due within one year |  | (52,207) |  |  | (52,052) |
Net current assets |  |  | (6,811) |  |  | (6,656)
Total assets less current liabilities |  |  | (6,980) |  |  | (6,825)
Net assets |  |  | (6,980) |  |  | (6,825)
Capital and reserves |  |  | (6,980) |  |  | (6,825)
NOTES TO THE ACCOUNTS General Information MEDICOEUR CONSULTING LTD is a private company, limited by shares, registered in England and Wales, registration number 13484277, registration address 1 VICTORIA COURT, BANK SQUARE, MORLEY LEEDS, LS27 9SE. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts. The financial statements were approved by the director on 10 November 2025 and were signed by:
-------------------------------- Richard Alexander Cardow Director
1